Promising Therapeutic Potential of miR-220-3p Mimic Against Murine Trimethyltin Hippocampal Injury
Iranian Journal of Pharmaceutical Research · 25.04.2026 · 25 (1)
DOI: 10.5812/ijpr-165755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 25.04.2026. Verfasst von Roya Khosh Ravesh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Iran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Trimethyltin (TMT) is an organotin compound known to induce neurotoxicity within the limbic system of the brain, particularly in the hippocampal region, with neurodegenerative changes resembling those of Alzheimer’s disease (AD).
Objectives
This investigation examined the impact of miRNA-220-3p (miR-220-3p) on TMT-induced neurotoxicity and associated behavioral abnormalities, such as spatial learning and memory impairments, and identified the potential molecular mechanisms.
Methods
To induce neurotoxicity, TMT was injected (8 mg/kg, i.p. once), and after 1 hour, miR-220-3p was microinjected intraventricularly (ICV route, once) for the possible mitigation of TMT-induced neurotoxicity. Different behavioral assessments were employed to determine spatial learning and memory function. Moreover, hippocampal measurements of brain-derived neurotrophic factor (BDNF) and Sirtuin-1, oxidative stress-, apoptosis-, and neuroinflammation-related factors, and histochemical changes were performed.
Results
The TMT injection led to behavioral abnormalities in the novel object discrimination and Barnes maze tests, heightened oxidative stress [elevating reactive oxygen species (ROS) levels, nitrite, and lipid peroxidation and decreasing the activities of antioxidant enzymes, including catalase (CAT) and superoxide dismutase (SOD)], reduced BDNF and Sirtuin-1 levels, increased neuroinflammation [escalating the secretion of pro-inflammatory mediators, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)], raised activities of acetylcholinesterase (AChE), myeloperoxidase (MPO), beta-secretase 1 (BACE-1), caspase-1, and caspase-3, accompanied by a reduced number of CA1 pyramidal neurons and higher glial fibrillary acidic protein (GFAP) immunoreactivity. In contrast, microinjection of miR-220-3p reversed most of these alterations.
Conclusions
The findings of this investigation imply that miR-220-3p may mitigate TMT-induced neurotoxicity, which is attributed to the suppression of hippocampal oxidative stress, neuroinflammation, and caspase-dependent apoptosis and pyroptosis, and part of its beneficial effect is associated with the upregulation of BDNF and Sirtuin-1.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Iran University of Medical Sciences, Tehran, Iran.
- Neurophysiology Research Center, Shahed University, Tehran, Iran.
ORCID-Profile: Mehrdad Roghani
Zitieren
APA
Khosh Ravesh, R., Khodashenas, V., Goudarzi, M., Mohammadi, L., Baluchnejadmojarad, T., & Roghani, M. (2026). Promising Therapeutic Potential of miR-220-3p Mimic Against Murine Trimethyltin Hippocampal Injury. Iranian Journal of Pharmaceutical Research, 25(1). https://doi.org/10.5812/ijpr-165755
Vancouver
Khosh Ravesh R, Khodashenas V, Goudarzi M, Mohammadi L, Baluchnejadmojarad T, Roghani M. Promising Therapeutic Potential of miR-220-3p Mimic Against Murine Trimethyltin Hippocampal Injury. Iranian Journal of Pharmaceutical Research. 2026;25(1). doi:10.5812/ijpr-165755
BibTeX
@article{KhoshRavesh2026,
author = {Khosh Ravesh, Roya and Khodashenas, Vahid and Goudarzi, Mina and Mohammadi, Leila and Baluchnejadmojarad, Tourandokht and Roghani, Mehrdad},
title = {Promising Therapeutic Potential of miR-220-3p Mimic Against Murine Trimethyltin Hippocampal Injury},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {1},
doi = {10.5812/ijpr-165755}
}
EUVIMED